Acquisition of the New Affinity 30 Vascular Color Doppler Ultrasound Device - Cost Benefit Analysis with the Aim of Reducing the Costs of Cardiosurgical Patients’ Treatment

Materia Socio Medica

article

Alen Karic¹  Adisa Oprasic-Dzordic²  Ervin Busevac¹  Alma Krajnovic¹  Nabil Naser³  Izet Masic⁴ 

[1]Department of Cardiovascular Surgery, Clinical Center of University of Sarajevo

[2]Privatna zdravstvena ustanva poliklinika Medicom

[3]Polyclinic "Nabil"

[4]Department of Family Medicine, Faculty of Medicine, University of Sarajevo

关键词: Cost benefit analysis;    Cerebrovascular accident;    Color doppler ultrasonography.;   

DOI  :  10.5455/msm.2023.35.65-72

学科分类：社会科学、人文和艺术（综合）

来源: Avicena d.o.o

【 摘 要 】

Background: Cerebrovascular accidents (CVI) are considered the second most serious complication in cardiac surgery patients with a frequency of 10%. By preventing complications of surgical treatment, using a Color Doppler ultrasound (CDU) device, in the population of cardiac surgery patients, the unplanned costs of prolonged postoperative treatment would be reduced. Objective: To prove that the acquisition and use of the new CDU device “Affinity 30” is completely economically profitable and medically justified. Methods: Numerical parameters of the treatment of cardiovascular patients were analyzed (number of procedures, number of days in the intensive care unit, cost of additional consultative services of the clinic for radiology and neurology), and the calculated economic value of the potential investment, as well as the cost of preventing surgical complications, by purchasing and using a new modern CDU device. The profitability of the investment was assessed using the economic parameters Net Present Value (NPV) of the investment, Internal rate of return (IRR) and Profitability Index (PI). Results: By mathematical calculations, with the given parameters, result in NPV=948,850 KM, IRR is 273%. The PI value is 12.6, which is in accordance with the previously calculated NPV and IRR values. Conclusion: The acquisition and use of the new CDU device “Affinity 30” is economically profitable and medically justified as shown by the calculated values of the economic parameters Net Present Value of the investment (NPV), Internal rate of return (IRR) and the Profitability Index (PI).

【 授权许可】

CC BY